The p53-estrogen receptor loop in cancer

C. Berger, Y. Qian, Xinbin Chen

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Tumor suppressor p53 maintains genome stability by regulating diverse cellular functions including cell cycle arrest, apoptosis, senescence and metabolic homeostasis. Mutations in the p53 gene occur in almost all human cancers with a frequency of up to 80%. However, it is only 20% in breast cancers, 18% in endometrial cancers and 1.5% in cervical cancers. Estrogen receptor alpha (ERα) plays a pivotal role in hormone-dependent cancer development and the status of ERα is used for designing treatment strategy and for prognosis. A closer look at the cross-talk between p53 and ERα has revealed that their activities are mutually regulated. This review will summarize the current body of knowledge on p53, ERα and ERβ in cancer. Clinical correlations between estrogen receptors and p53 status have also been reported. Thus, this review will discuss the relationship between p53 and ERs at both the molecular and clinical levels.

Original languageEnglish (US)
Pages (from-to)1229-1240
Number of pages12
JournalCurrent Molecular Medicine
Volume13
Issue number8
DOIs
StatePublished - Sep 2013

Fingerprint

Estrogen Receptor alpha
Estrogen Receptors
Neoplasms
Genes
Genomic Instability
p53 Genes
Endometrial Neoplasms
Cell Cycle Checkpoints
Uterine Cervical Neoplasms
Tumors
Homeostasis
Cells
Hormones
Apoptosis
Breast Neoplasms
Mutation

Keywords

  • Estrogen receptor
  • Hormone-dependent cancer
  • P53
  • Transcription factors

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Molecular Medicine

Cite this

The p53-estrogen receptor loop in cancer. / Berger, C.; Qian, Y.; Chen, Xinbin.

In: Current Molecular Medicine, Vol. 13, No. 8, 09.2013, p. 1229-1240.

Research output: Contribution to journalArticle

Berger, C. ; Qian, Y. ; Chen, Xinbin. / The p53-estrogen receptor loop in cancer. In: Current Molecular Medicine. 2013 ; Vol. 13, No. 8. pp. 1229-1240.
@article{c07379eb66754972b3ac0841f4a0547f,
title = "The p53-estrogen receptor loop in cancer",
abstract = "Tumor suppressor p53 maintains genome stability by regulating diverse cellular functions including cell cycle arrest, apoptosis, senescence and metabolic homeostasis. Mutations in the p53 gene occur in almost all human cancers with a frequency of up to 80{\%}. However, it is only 20{\%} in breast cancers, 18{\%} in endometrial cancers and 1.5{\%} in cervical cancers. Estrogen receptor alpha (ERα) plays a pivotal role in hormone-dependent cancer development and the status of ERα is used for designing treatment strategy and for prognosis. A closer look at the cross-talk between p53 and ERα has revealed that their activities are mutually regulated. This review will summarize the current body of knowledge on p53, ERα and ERβ in cancer. Clinical correlations between estrogen receptors and p53 status have also been reported. Thus, this review will discuss the relationship between p53 and ERs at both the molecular and clinical levels.",
keywords = "Estrogen receptor, Hormone-dependent cancer, P53, Transcription factors",
author = "C. Berger and Y. Qian and Xinbin Chen",
year = "2013",
month = "9",
doi = "10.2174/15665240113139990065",
language = "English (US)",
volume = "13",
pages = "1229--1240",
journal = "Current Molecular Medicine",
issn = "1566-5240",
publisher = "Bentham Science Publishers B.V.",
number = "8",

}

TY - JOUR

T1 - The p53-estrogen receptor loop in cancer

AU - Berger, C.

AU - Qian, Y.

AU - Chen, Xinbin

PY - 2013/9

Y1 - 2013/9

N2 - Tumor suppressor p53 maintains genome stability by regulating diverse cellular functions including cell cycle arrest, apoptosis, senescence and metabolic homeostasis. Mutations in the p53 gene occur in almost all human cancers with a frequency of up to 80%. However, it is only 20% in breast cancers, 18% in endometrial cancers and 1.5% in cervical cancers. Estrogen receptor alpha (ERα) plays a pivotal role in hormone-dependent cancer development and the status of ERα is used for designing treatment strategy and for prognosis. A closer look at the cross-talk between p53 and ERα has revealed that their activities are mutually regulated. This review will summarize the current body of knowledge on p53, ERα and ERβ in cancer. Clinical correlations between estrogen receptors and p53 status have also been reported. Thus, this review will discuss the relationship between p53 and ERs at both the molecular and clinical levels.

AB - Tumor suppressor p53 maintains genome stability by regulating diverse cellular functions including cell cycle arrest, apoptosis, senescence and metabolic homeostasis. Mutations in the p53 gene occur in almost all human cancers with a frequency of up to 80%. However, it is only 20% in breast cancers, 18% in endometrial cancers and 1.5% in cervical cancers. Estrogen receptor alpha (ERα) plays a pivotal role in hormone-dependent cancer development and the status of ERα is used for designing treatment strategy and for prognosis. A closer look at the cross-talk between p53 and ERα has revealed that their activities are mutually regulated. This review will summarize the current body of knowledge on p53, ERα and ERβ in cancer. Clinical correlations between estrogen receptors and p53 status have also been reported. Thus, this review will discuss the relationship between p53 and ERs at both the molecular and clinical levels.

KW - Estrogen receptor

KW - Hormone-dependent cancer

KW - P53

KW - Transcription factors

UR - http://www.scopus.com/inward/record.url?scp=84884193685&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84884193685&partnerID=8YFLogxK

U2 - 10.2174/15665240113139990065

DO - 10.2174/15665240113139990065

M3 - Article

C2 - 23865427

AN - SCOPUS:84884193685

VL - 13

SP - 1229

EP - 1240

JO - Current Molecular Medicine

JF - Current Molecular Medicine

SN - 1566-5240

IS - 8

ER -